eMAX Health 2.0 has filed a notice of an exempt offering of securities to raise $3,800,595.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, eMAX Health 2.0 is raising up to $3,800,595.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About eMAX Health 2.0
eMAX Health Systems provides value-driven, global turnkey professional services to implement accountable care. eMAX Health Systems, LLC was established in 2004 to provide independent research and innovative pharmaceutical distribution support across various segments of the global healthcare system. eMAX Health offers independent outcomes monitoring, rebate adjudication, and administrative reporting services, bringing competing interests together to improve health outcomes and lower cost. eMAX Health Research and Analytics: Through an independent global analytics research team, we conduct comparative effectiveness research to assess the value of pharmaceutical products. eMAX Health Patient Access Center: Through a prescription drug patient access center, we help implement medical policy by managed care organizations to improve patient access to needed treatments.
To learn more about eMAX Health 2.0, visit http://www.emaxhealth.net/
eMAX Health 2.0 Linkedin Page: https://www.linkedin.com/company/emax-health-systems-llc/
Contact:
Julian Casciano, Chief Executive Officer
914-302-6809
https://www.linkedin.com/in/juliancasciano/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.